$0.97
▼ -0.1% Today
as of Aug 5, 16:48 ET
Last 30 days
Recent Press Releases & News
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
Overview
52-week range
$0.65
$1.35
46% of range
Avg surprise (last 1)
0.0%
Avg reaction (last 2)
-1.6%
0% positive
Latest IV / EM
1852%
EM ±309.4% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.05 | — | — | +28.6% | -1.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.06 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.06 | $-0.06 | 0.0% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.07 | — | — | — | -1.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.01 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.07 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | -$0.03 | -$0.06 | +50.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | — | $1M | $966,630 | $393,572 | — | $2M | $385,896 |
| Cost of revenue | $791,840 | — | $1M | — | $297,658 | — | $395,894 | $301,956 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-2M | — | $-2M | $-2M | $-2M | — | $-202,614 | $-2M |
| Net income | $-2M | — | $-2M | $-2M | $-2M | — | $-203,460 | $-2M |
| EPS (diluted) | $-0.05 | — | $-0.06 | $-0.06 | $-0.07 | — | $-0.01 | $-0.07 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $5M | $6M | $2M | $5M | $7M | $6M | $6M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $8M | $10M | $12M | $7M | $8M | $10M | $11M | $11M |
| Total assets | $8M | $10M | $12M | $8M | $8M | $10M | $11M | $11M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $8M | $9M | $9M | $9M | $7M | $7M | $7M | $7M |
| Total equity | $-407,732 | $1M | $3M | $-529,701 | $923,611 | $2M | $3M | $3M |